Research suggests that the body's immune response to contracting Epstein-Barr virus (EBV) increases a person's likelihood of developing MS. Using a brain organoid model exposed to EBV, researchers are studying the mechanisms by which EBV contributes to MS. We are also investigating EBV-related immune activation markers in response to different treatments and stages of disease.